Edition:
United Kingdom

People: Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

4.51USD
6:17pm BST
Change (% chg)

$0.20 (+4.64%)
Prev Close
$4.31
Open
$4.31
Day's High
$4.55
Day's Low
$4.25
Volume
51,954
Avg. Vol
252,496
52-wk High
$28.74
52-wk Low
$4.17

Davison, Daniel 

Mr. Dan Davison is appointed as Chief Financial Officer, Treasurer of the Company, effective April 8, 2019. He has over 25 years of experience in the pharmacy benefit management (“PBM”) and specialty pharmacy industries. Mr. Davison has deep expertise in pricing and business strategy, trade analytics, business development, financial planning and analysis, accounting and financial reporting and risk management. Prior to joining the Company, Mr. Davison served as Senior Vice President, PBM Finance of CVS Health (NYSE: CVS), one of the largest health care companies in the United States, from January 2014 to December 2018, where he managed the finance, planning and accounting functions for the CVS/Caremark and CVS/Specialty groups within the CVS Pharmacy Services Segment. Prior to this position, Mr. Davison served from 1994 to 2012 in a number of leadership roles at Medco Health Solutions, Inc., a provider of PBM and specialty pharmaceutical services (which merged with Express Scripts Holding Company, Inc. in April 2012), including as Senior Vice President of Financial and Strategic Planning from March 2008 to April 2012 and chief financial officer of the Health Plan division from April 2004 to March 2008. Mr. Davison received a B.B.A. in Accounting and a B.A. in Economics from Iowa State University and an M.B.A. in Finance from the New York University Leonard N. Stern School of Business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --